Thrombosis
News
A 4-point thrombocytopenia score was found able to rule out suspected HIT
News
NETs a possible therapeutic target for COVID-19 thrombosis?
News
COVID-19 anticoagulation trials ‘paused’ for futility, safety
The trials involved are the REMAP-CAP, ACTIV-4, and ATTACC studies.
Clinical
A multicenter trial of vena cava filters in severely injured patients
Can early (within 72 hours) prophylactic placement of inferior vena cava filter decrease the risk of pulmonary embolism or death in severely...
News
COVID-19 and risk of clotting: ‘Be proactive about prevention’
"We believe a systematic way of addressing this risk is best, with every patient hospitalized with COVID-19 receiving some type of...
News
Cost is the main hurdle to broad use of caplacizumab for TTP
“If we take finances out, I think almost every patient except those with a bleeding risk or bleeding problem should get it,” an investigator said...
News
What to do when anticoagulation fails cancer patients
News
Liver injury linked to COVID-19–related coagulopathy
Cells that line the liver’s blood vessels produce high levels of factor VIII, a coagulation factor, when they are exposed to interleukin-6, an...
News
Factor XI inhibitor–based anticoagulation strategies gain ground
“When we compare the FXI inhibitors with existing anticoagulants, we don’t necessarily want to go up against the DOACs.”
News
COVID-19: Thromboembolic events high despite prophylaxis
“Standard prophylaxis as recommended in the guidelines is a low dose of low-molecular-weight...